XML 45 R24.htm IDEA: XBRL DOCUMENT v3.3.0.814
REVENUES BY PRODUCT CATEGORY AND GEOGRAPHIC REGION AND SIGNIFICANT CONCENTRATIONS
6 Months Ended
Sep. 30, 2015
REVENUES BY PRODUCT CATEGORY AND GEOGRAPHIC REGION AND SIGNIFICANT CONCENTRATIONS [Abstract]  
REVENUES BY PRODUCT CATEGORY AND GEOGRAPHIC REGION AND SIGNIFICANT CONCENTRATIONS
NOTE 18.REVENUES BY PRODUCT CATEGORY AND GEOGRAPHIC REGION AND SIGNIFICANT CONCENTRATIONS

Revenue Information

The following is a summary of our revenues by product category and represents our results from continuing operations (in thousands):

  
Three Months Ended
September 30,
  
Six Months Ended
September 30,
 
Revenues by Product Category
 
2015
  
2014
  
2015
  
2014
 
Instruments (1)
 
$
11,597
  
$
10,105
  
$
20,309
  
$
17,699
 
Consumables (2)
  
41,675
   
38,138
   
83,472
   
72,424
 
Other products (3)
  
2,703
   
2,191
   
5,247
   
4,328
 
Product sales, net
  
55,975
   
50,434
   
109,028
   
94,451
 
Development and licensing revenues
  
-
   
37
   
37
   
74
 
Total revenues
 
$
55,975
  
$
50,471
  
$
109,065
  
$
94,525
 
 

(1)Instruments include chemistry analyzers, hematology instruments, VSpro specialty analyzers and i‑STAT analyzers.
(2)Consumables include reagent discs, hematology reagent kits, VSpro specialty cartridges, i‑STAT cartridges and rapid tests.
(3)Other products include products using the Orbos process and extended maintenance agreements.
 
The following is a summary of our revenues by geographic region based on customer location and represents our results from continuing operations (in thousands):

  
Three Months Ended
September 30,
  
Six Months Ended
September 30,
 
Revenues by Geographic Region
 
2015
  
2014
  
2015
  
2014
 
North America
 
$
45,176
  
$
41,039
  
$
87,487
  
$
75,956
 
Europe
  
8,262
   
7,244
   
15,985
   
14,528
 
Asia Pacific and rest of the world
  
2,537
   
2,188
   
5,593
   
4,041
 
Total revenues
 
$
55,975
  
$
50,471
  
$
109,065
  
$
94,525
 
 
Significant Concentrations

During the three months ended September 30, 2015, three distributors in the United States, MWI Veterinary Supply, Inc., Henry Schein Animal Health and Patterson Companies, Inc. accounted for 20%, 12% and 12%, respectively, of our total worldwide revenues. During the six months ended September 30, 2015, three distributors in the United States, MWI Veterinary Supply, Inc., Henry Schein Animal Health and Patterson Companies, Inc. accounted for 20%, 12% and 10%, respectively, of our total worldwide revenues. Starting in the second quarter of fiscal 2016, our revenues from Patterson Companies, Inc. include both Patterson’s veterinary business and Animal Health International, Inc., as a result of Patterson’s recent acquisition.

During the three months ended September 30, 2014, one distributor in the United States, MWI Veterinary Supply, accounted for 20% of our total worldwide revenues. During the six months ended September 30, 2014, one distributor in the United States, MWI Veterinary Supply, accounted for 18% of our total worldwide revenues.

Concentration of credit risk with respect to accounts receivable is primarily limited to certain distributors to whom we make significant sales. One distributor in the United States accounted for 23% of our total receivable balance as of September 30, 2015. One distributor in the United States accounted for 26% of our total receivable balance as of March 31, 2015.